Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia. Haddad F, Kantarjian H, Issa GC, Jabbour E, et al. Leuk Lymphoma 2022 Apr 1:1-4. doi: 10.1080/10428194.2022.2045599.

Read + Share

Amedeo Smart

Independent Medical Education

Haddad F, Kantarjian H, Issa GC, Jabbour E, et al. Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia. Leuk Lymphoma 2022 Apr 1:1-4. doi: 10.1080/10428194.2022.2045599.
PMID: 35361036